Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy

NCT03448926 is registered in ClinicalTrials.gov with PreludeDx as lead sponsor.

NCT NCT03448926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03448926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
Lead sponsor
PreludeDx
Phase
Observational
Overall status
Recruiting
Start date
February 27, 2018
Completion date
December 31, 2036
Enrollment
3,000 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

dcis, ductal breast carcinoma in situ, stage 0 breast cancer